CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
about
Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinomaThe genetic and epigenetic alterations in human hepatocellular carcinoma: a recent updateCancer-associated fibroblasts in digestive tumorsSystemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsChromodomain Helicase/ATPase DNA-Binding Protein 1-Like Gene (CHD1L) Expression and Implications for Invasion and Metastasis of Breast CancerCdc42 in oncogenic transformation, invasion, and tumorigenesisInitial steps of metastasis: cell invasion and endothelial transmigrationOverexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaInter-kingdom Signaling by the Legionella Quorum Sensing Molecule LAI-1 Modulates Cell Migration through an IQGAP1-Cdc42-ARHGEF9-Dependent PathwayA novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and disseminationDDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin.Small molecule targeting Cdc42-intersectin interaction disrupts Golgi organization and suppresses cell motility.For robust big data analyses: a collection of 150 important pro-metastatic genesEpithelial-mesenchymal transitions and hepatocarcinogenesis.CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.Activating transcription factor 4 promotes esophageal squamous cell carcinoma invasion and metastasis in mice and is associated with poor prognosis in human patients.Presence of CHD1L over-expression is associated with aggressive tumor biology and is a novel prognostic biomarker for patient survival in human breast cancerMesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition.CHD1L protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival.Chromodomain helicase/ATPase DNA binding protein 1-like protein expression predicts poor prognosis in nasopharyngeal carcinoma.The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancerMicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma.SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.Overexpression of N-terminal kinase like gene promotes tumorigenicity of hepatocellular carcinoma by regulating cell cycle progression and cell motility.Morphine promotes cancer stem cell properties, contributing to chemoresistance in breast cancer.MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets.Activation of the SNF2 family ATPase ALC1 by poly(ADP-ribose) in a stable ALC1·PARP1·nucleosome intermediate.Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival.SNF2H promotes hepatocellular carcinoma proliferation by activating the Wnt/β-catenin signaling pathwayCHD1L: a novel oncogene.Chromosome 1q21 amplification and oncogenes in hepatocellular carcinoma.Tumor initiation and progression in hepatocellular carcinoma: risk factors, classification, and therapeutic targets.Rnd3/RhoE Is down-regulated in hepatocellular carcinoma and controls cellular invasion.Cellular and molecular mechanisms of hepatocellular carcinoma: an update.Reprogramming cellular events by poly(ADP-ribose)-binding proteinsMacro domains as metabolite sensors on chromatin.CHD1L Expression Increases Tumor Progression and Acts as a Predictive Biomarker for Poor Prognosis in Pancreatic Cancer.Polymeric immunoglobulin receptor promotes tumor growth in hepatocellular carcinoma.CHD1L Regulates Cell Cycle, Apoptosis, and Migration in Glioma.Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis.
P2860
Q21092852-E3E73405-CC25-4270-B8C4-6F5C7DAB464FQ27003050-E7C11564-A050-45DA-8787-37DC2284B21BQ27022816-CE52FC75-34B5-49C9-AB7D-74AD652F9A7DQ27311589-4853A8E2-F055-4E4D-9C47-DEF4037E03ECQ27342714-F84B3117-D907-4A62-B60D-BEAF45743E89Q28236231-FB5E55EE-96CA-41F4-A45A-3DD7770E8817Q28238397-0A9B9B11-BBC2-4106-925E-4461FAF12D5BQ28273449-8DB424EE-7B0D-49CC-9505-39ABF651F42AQ28551293-FAF3F675-66BB-4F5F-97E2-945411C27112Q28597820-E5C4CCFC-8B07-4C63-8C9D-143F1A7A6C54Q30499285-DA277D36-3779-4647-9BFE-328DC9557E88Q30533280-38E57F69-4356-4D07-9FEF-099C1C02F58BQ31155755-6776B716-0D40-4BA5-ADD3-6AC0605E298CQ33755466-03E5C201-487D-40A7-BCA3-40E314EF8D75Q33757826-08864D7E-260A-4AF3-8829-104D4EA13C19Q33982416-81F7BC1B-6CBF-46B7-A6A0-208AE95CB3FAQ34083417-739C29F4-488C-48A8-BF20-008399529BC9Q34405052-ED665F86-A347-4669-AFD3-5DC3D32A902BQ34424030-883CD655-25CB-416A-A183-B63A8BFDA0D7Q34443999-FF1E843B-96B9-4683-8332-60A3B4070C67Q34771536-C79127AC-4828-43C0-BEE6-CB5ED6ADF0B8Q34956599-C0C90B75-BB3A-4729-BDF3-6CA1E9676DCDQ35061390-18D8CC0F-9E3D-4E0D-AE7A-2513CBDBE3D5Q35176391-8A7E012C-40D0-4269-A36D-0ACD84AFC439Q35551918-DF6BE8E5-19EC-4788-A57A-94B198592DDAQ35809301-16F8EE9A-FD47-4008-8697-1CCB9DD8D932Q36481781-41144942-C529-4E44-96DD-A3F59D3E6CF2Q36544520-32637465-6F01-4627-AE34-6E6CA397E3ACQ37107860-2676489F-B0DE-4A66-88DF-A016731144FDQ37597560-5B23490B-3561-473A-B951-57B0E9A47DBEQ37777019-B090F4D1-BF16-442C-B1DF-2647321CA67AQ37800793-6958FEE1-AC4C-46DB-BB8B-1EBB02DCF6D9Q37974881-EC40864E-34EE-45EA-A6C4-7ACE983FE9D4Q38046107-555D978A-AF06-457F-B3CA-B6AAC7C02560Q38069879-1FFF2A91-69C9-48EF-958F-5C9C838D2C00Q38086003-AFB6C0C4-D3C3-40C9-AE42-40B908F8F124Q38711185-B86C8D6C-DCC3-4453-BB88-FF927D0F5959Q38722084-9BBC6071-4689-4E82-B6D7-F621CCDCA0C4Q38854438-4A6885E7-D7B5-48C8-8636-F4E2E220C84EQ38971921-4E39AFEB-BC46-4E0B-AF23-2B83F524EBD3
P2860
CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CHD1L promotes hepatocellular ...... e processes in human patients.
@ast
CHD1L promotes hepatocellular ...... e processes in human patients.
@en
type
label
CHD1L promotes hepatocellular ...... e processes in human patients.
@ast
CHD1L promotes hepatocellular ...... e processes in human patients.
@en
prefLabel
CHD1L promotes hepatocellular ...... e processes in human patients.
@ast
CHD1L promotes hepatocellular ...... e processes in human patients.
@en
P2093
P2860
P50
P356
P1476
CHD1L promotes hepatocellular ...... se processes in human patients
@en
P2093
Kwan Ho Tang
Sui-Sui Dong
Tim Hon Man Chan
P2860
P304
P356
10.1172/JCI40665
P407
P577
2010-03-24T00:00:00Z